Abelacimab Completed Phase 2 Trials for Atrial Fibrillation Prevention
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Prevention | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT04213807 | A Dose-range Finding Study of MAA868 in Patients With Atrial Fibrillation |